APA Releases Revamped Practice Guideline on Eating Disorders
APA has released an updatedpractice guideline on how to assess and treat patients with eating disorders—the first full update since 2006. The fourth edition of APA’s Practice Guideline for the Treatment of Patients With Eating Disorders reflects numerous new research findings since 2006 as well as diagnostic changes following the publication ofDSM-5 in 2013 andDSM-5-TR in 2022.“Eating disorders often are unrecognized and untreated,” noted Catherine Crone, M.D., chair of the practice guideline writing group, in anAPA press release. “This guideline and supplementary resources are intended to serve as a practical to...
Source: Psychiatr News - February 27, 2023 Category: Psychiatry Tags: anorexia binge-eating disorder bulimia eating disorders practice guideline psychiatric evaluation psychotherapy Source Type: research

Youth With Anxiety May Experience Worsening Symptoms After COVID-19
Youth with anxiety disorders who contract COVID-19 may experience worsening anxiety symptoms, suggests asmall study reported in a letter in theJournal of the American Academy of Child& Adolescent Psychiatry.Jeffrey R. Strawn, M.D., of the University of Cincinnati and colleagues analyzed data collected from a longitudinal study of adolescents aged 12 to 17 who had been diagnosed with primary anxiety disorders and were being treated with duloxetine or escitalopram. At the start of the study in December 2019, these youth participated in weekly follow-up visits, where they were evaluated using several measures, including t...
Source: Psychiatr News - February 24, 2023 Category: Psychiatry Tags: adolescents anxiety COVID-19 Journal of the Academy of Child & Adolescent Psychiatry youth Source Type: research

Prazosin May Reduce Drinking in Some Individuals With AUD
Prazosin —a medication commonly used to treat high blood pressure—may also reduce drinking by adults with alcohol use disorder (AUD), according to aclinical trial involving active-duty military appearing inAlcohol: Clinical and Experimental Research. Adults with elevated heart rate or blood pressure seemed to benefit the most from this medication.Murray Raskind, M.D., of the VA Puget Sound Health Care System and colleagues enrolled 102 active-duty soldiers (95% male) who were participating in a mandated Army outpatient alcohol treatment program. All participants had to be in good overall health, meetDSM-IV criteria for...
Source: Psychiatr News - February 23, 2023 Category: Psychiatry Tags: active-duty military alcohol use disorder Alcohol: Clinical and Experimental Research blood pressure drinking Prazosin PTSD Source Type: research

Memantine May Reduce Symptoms of Hair-Pulling, Skin-Picking Disorder
Patients with trichotillomania (also known as hair-pulling disorder) and/or excoriation (skin-picking) disorder may experience symptom improvements while taking the Alzheimer ' s medication memantine, areport published today inAJP in Advance suggests.Trichotillomania and excoriation disorder are characterized by repetitive behaviors focused on the body and intrusive urges that are believed to be driven in part by the glutamate system. Memantine, which is approved by the FDA for moderate to severe Alzheimer ’s disease, works by regulating the activity of glutamate.To test the safety and effectiveness of memantine compared...
Source: Psychiatr News - February 22, 2023 Category: Psychiatry Tags: ajp in advance Alzheimer ' s medication excoriation FDA hair-pulling disorder memantine NIMH Trichotillomania Symptom Severity Scale skin-picking disorder Source Type: research

FDA Advisory Panel Recommends Approval for Over-the-Counter Narcan
Last week the U.S. Food and Drug Administration (FDA) Nonprescription Drugs Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee voted unanimously, 19-0, to recommend that Narcan (naloxone HCl) 4 mg nasal spray be made available without a prescription, Emergent BioSolutionsannounced. The medication reverses an opioid overdose by blocking the effects of opioids.The FDA is not bound by the committees ’ guidance but will take their advice into consideration when it makes its decision on whether to make the drug available over the counter (OTC). If approved, Narcan would be the first OTC nalox...
Source: Psychiatr News - February 21, 2023 Category: Psychiatry Tags: Food and Drug Administration naloxone narcan opioid overdose over-the-counter STAT Source Type: research